Literature DB >> 11092657

Pre-existing arterial remodeling is associated with in-hospital and late adverse cardiac events after coronary interventions in patients with stable angina pectoris.

P Wexberg1, M Gyöngyösi, W Sperker, K Kiss, P Yang, A Hassan, G Pasterkamp, D Glogar.   

Abstract

OBJECTIVES: The goal of this study was to investigate the association between the atherosclerotic arterial remodeling and the incidence of cardiac events after coronary interventions in patients with stable angina.
BACKGROUND: The local mode of de novo atherosclerotic remodeling is associated with plaque vulnerability and clinical symptoms. It may, therefore, reflect plaque morphology influencing the long-term outcome after coronary interventions.
METHODS: Quantitative angiography and intravascular ultrasound were obtained in 244 patients with stable angina before and after single-vessel revascularization. On the basis of the lesion and the reference segment vessel size, patients were categorized into three groups (adaptive [AR], constrictive [CR] and intermediate [IR] remodeling). The lesion was analyzed for lumen, total vessel and plaque areas. Clinical follow-up was obtained at a mean period of 7.7+/-3.7 months.
RESULTS: Patients with CR had a higher rate of in-hospital complications (10.9% vs. 2.9% and 2.7% in group CR vs. AR and IR, p = 0.035). In contrast, patients with AR had the highest rate of major adverse cardiac events (MACE) (44.3% vs. 25.5% in IR and 28.1% in CR, p = 0.024) with a predominance of revascularization at follow-up. Both target lesion restenosis (p = 0.036) and nontarget lesion de novo stenosis (p = 0.007) occurred more frequently in this group. Adaptive remodeling was a significant predictor of MACE in multivariate analysis.
CONCLUSIONS: Adaptive remodeling is associated with a higher rate of MACE, target lesion restenosis and nontarget de novo stenosis. This finding may be due to differential responses of the adaptively remodeled vessel to revascularization and a generally accelerated course of systemic atherosclerosis.

Entities:  

Mesh:

Year:  2000        PMID: 11092657     DOI: 10.1016/s0735-1097(00)00949-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

Review 1.  Coronary arterial remodeling: from bench to bedside.

Authors:  Paul Schoenhagen; Steven E Nissen; E Murat Tuzcu
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

2.  Impact of arterial remodelling and plaque rupture on target and non-target lesion revascularisation after stent implantation in patients with acute coronary syndrome: an intravascular ultrasound study.

Authors:  Hiroyuki Okura; Haruyuki Taguchi; Tomoichiro Kubo; Iku Toda; Minoru Yoshiyama; Junichi Yoshikawa; Kiyoshi Yoshida
Journal:  Heart       Date:  2007-03-29       Impact factor: 5.994

Review 3.  What has intravascular ultrasound taught us about plaque biology?

Authors:  S Kinlay
Journal:  Curr Atheroscler Rep       Date:  2001-05       Impact factor: 5.113

4.  Patterns and Implications of Intracranial Arterial Remodeling in Stroke Patients.

Authors:  Ye Qiao; Zeeshan Anwar; Jarunee Intrapiromkul; Li Liu; Steven R Zeiler; Richard Leigh; Yiyi Zhang; Eliseo Guallar; Bruce A Wasserman
Journal:  Stroke       Date:  2016-01-07       Impact factor: 7.914

5.  Morphologic characteristics of atherosclerotic middle cerebral arteries on 3T high-resolution MRI.

Authors:  X J Zhu; B Du; X Lou; F K Hui; L Ma; B W Zheng; M Jin; C X Wang; W-J Jiang
Journal:  AJNR Am J Neuroradiol       Date:  2013-05-02       Impact factor: 3.825

Review 6.  High-resolution Magnetic Resonance Vessel Wall Imaging for Intracranial Arterial Stenosis.

Authors:  Xian-Jin Zhu; Wu Wang; Zun-Jing Liu
Journal:  Chin Med J (Engl)       Date:  2016-06-05       Impact factor: 2.628

7.  Smaller outer diameter of atherosclerotic middle cerebral artery associated with RNF213 c.14576G>A Variant (rs112735431).

Authors:  Hiroki Hongo; Satoru Miyawaki; Hideaki Imai; Yuki Shinya; Hideaki Ono; Harushi Mori; Hirofumi Nakatomi; Akira Kunimatsu; Nobuhito Saito
Journal:  Surg Neurol Int       Date:  2017-06-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.